Concepts (214)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deep Brain Stimulation | 7 | 2025 | 427 | 2.750 |
Why?
|
| Fornix, Brain | 5 | 2025 | 20 | 1.780 |
Why?
|
| Rett Syndrome | 7 | 2023 | 294 | 1.610 |
Why?
|
| Fear | 10 | 2021 | 208 | 1.320 |
Why?
|
| Hippocampus | 8 | 2025 | 862 | 1.180 |
Why?
|
| Memory | 7 | 2025 | 358 | 1.010 |
Why?
|
| Dentate Gyrus | 3 | 2021 | 55 | 0.910 |
Why?
|
| Neural Inhibition | 3 | 2021 | 112 | 0.900 |
Why?
|
| Nerve Net | 1 | 2025 | 259 | 0.750 |
Why?
|
| Epileptic Syndromes | 1 | 2021 | 32 | 0.720 |
Why?
|
| Spasms, Infantile | 1 | 2021 | 175 | 0.640 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 7 | 2023 | 312 | 0.630 |
Why?
|
| Mice | 30 | 2025 | 18884 | 0.560 |
Why?
|
| Long-Term Potentiation | 6 | 2015 | 163 | 0.540 |
Why?
|
| Neuronal Plasticity | 5 | 2018 | 288 | 0.490 |
Why?
|
| Parkinson Disease | 1 | 2021 | 732 | 0.450 |
Why?
|
| Mice, Inbred C57BL | 14 | 2025 | 4800 | 0.440 |
Why?
|
| Animals | 33 | 2025 | 36364 | 0.440 |
Why?
|
| Neurons | 10 | 2025 | 2034 | 0.440 |
Why?
|
| Amygdala | 3 | 2003 | 87 | 0.420 |
Why?
|
| Evoked Potentials, Auditory | 3 | 2006 | 53 | 0.410 |
Why?
|
| Neurogenesis | 3 | 2023 | 225 | 0.410 |
Why?
|
| Nicotine | 2 | 2010 | 147 | 0.370 |
Why?
|
| Avoidance Learning | 2 | 2021 | 59 | 0.360 |
Why?
|
| Behavior, Animal | 9 | 2020 | 522 | 0.340 |
Why?
|
| Conditioning, Classical | 3 | 2009 | 54 | 0.320 |
Why?
|
| Nicotinic Agonists | 1 | 2009 | 45 | 0.320 |
Why?
|
| Dopamine | 2 | 2014 | 284 | 0.310 |
Why?
|
| Gyrus Cinguli | 3 | 2005 | 135 | 0.310 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2010 | 152 | 0.290 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2021 | 87 | 0.290 |
Why?
|
| Haploinsufficiency | 2 | 2020 | 274 | 0.270 |
Why?
|
| Seizures | 4 | 2022 | 889 | 0.270 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2025 | 59 | 0.230 |
Why?
|
| Mice, 129 Strain | 2 | 2021 | 99 | 0.220 |
Why?
|
| Gene Expression | 4 | 2016 | 1614 | 0.210 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2023 | 122 | 0.200 |
Why?
|
| Auditory Pathways | 1 | 2001 | 20 | 0.190 |
Why?
|
| Protein Biosynthesis | 1 | 2005 | 676 | 0.190 |
Why?
|
| Electrodes | 1 | 2021 | 97 | 0.190 |
Why?
|
| Pain | 1 | 2005 | 478 | 0.190 |
Why?
|
| Electroencephalography | 3 | 2022 | 905 | 0.180 |
Why?
|
| Organ Culture Techniques | 1 | 2021 | 162 | 0.180 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2023 | 449 | 0.170 |
Why?
|
| Cleavage And Polyadenylation Specificity Factor | 1 | 2020 | 15 | 0.170 |
Why?
|
| Male | 18 | 2025 | 65815 | 0.170 |
Why?
|
| Munc18 Proteins | 1 | 2020 | 20 | 0.170 |
Why?
|
| Chromatin | 1 | 2023 | 609 | 0.160 |
Why?
|
| Polyadenylation | 1 | 2020 | 57 | 0.160 |
Why?
|
| Mice, Transgenic | 3 | 2021 | 2527 | 0.160 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2019 | 19 | 0.160 |
Why?
|
| Behavior | 1 | 2019 | 75 | 0.150 |
Why?
|
| Genes, Duplicate | 2 | 2015 | 16 | 0.150 |
Why?
|
| Disease Models, Animal | 7 | 2020 | 4772 | 0.150 |
Why?
|
| Respiratory System | 1 | 2018 | 100 | 0.140 |
Why?
|
| Respiratory Center | 1 | 2017 | 10 | 0.140 |
Why?
|
| Substance P | 1 | 2017 | 38 | 0.140 |
Why?
|
| Nerve Degeneration | 1 | 2018 | 129 | 0.130 |
Why?
|
| Motor Neurons | 1 | 2018 | 156 | 0.130 |
Why?
|
| Brain Diseases | 1 | 2020 | 311 | 0.130 |
Why?
|
| Gene Dosage | 2 | 2015 | 456 | 0.130 |
Why?
|
| Sodium Channels | 1 | 2017 | 109 | 0.130 |
Why?
|
| RNA Splicing | 1 | 2018 | 250 | 0.130 |
Why?
|
| Acoustic Stimulation | 4 | 2006 | 85 | 0.130 |
Why?
|
| GABAergic Neurons | 1 | 2016 | 65 | 0.120 |
Why?
|
| Spatial Learning | 1 | 2015 | 16 | 0.120 |
Why?
|
| Sodium | 1 | 2017 | 307 | 0.120 |
Why?
|
| Tauopathies | 1 | 2016 | 77 | 0.120 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2016 | 80 | 0.120 |
Why?
|
| Cognition Disorders | 2 | 2020 | 579 | 0.120 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2018 | 254 | 0.120 |
Why?
|
| Receptors, Adrenergic | 1 | 2014 | 28 | 0.120 |
Why?
|
| Receptors, Dopamine | 1 | 2014 | 41 | 0.110 |
Why?
|
| Protein Kinases | 1 | 2016 | 343 | 0.110 |
Why?
|
| Perforant Pathway | 2 | 2014 | 13 | 0.110 |
Why?
|
| Methylphenidate | 1 | 2014 | 58 | 0.110 |
Why?
|
| Extinction, Psychological | 2 | 2006 | 26 | 0.110 |
Why?
|
| Aging | 2 | 2019 | 1304 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 395 | 0.110 |
Why?
|
| tau Proteins | 1 | 2016 | 241 | 0.110 |
Why?
|
| Central Nervous System Stimulants | 1 | 2014 | 131 | 0.110 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 609 | 0.100 |
Why?
|
| Developmental Disabilities | 1 | 2018 | 733 | 0.100 |
Why?
|
| Female | 11 | 2023 | 71586 | 0.100 |
Why?
|
| Nervous System Diseases | 1 | 2016 | 408 | 0.090 |
Why?
|
| Calcium | 1 | 2017 | 1146 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2016 | 869 | 0.090 |
Why?
|
| Mutation | 4 | 2023 | 6289 | 0.090 |
Why?
|
| Brain | 2 | 2023 | 3217 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1911 | 0.090 |
Why?
|
| Cognition | 1 | 2015 | 815 | 0.080 |
Why?
|
| Bipolar Disorder | 1 | 2013 | 367 | 0.080 |
Why?
|
| Synaptic Potentials | 1 | 2009 | 14 | 0.080 |
Why?
|
| Mesencephalon | 1 | 2009 | 38 | 0.080 |
Why?
|
| Mice, Knockout | 5 | 2020 | 3969 | 0.080 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2009 | 88 | 0.080 |
Why?
|
| Pyramidal Cells | 2 | 2022 | 172 | 0.070 |
Why?
|
| Neural Pathways | 1 | 2009 | 285 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2020 | 3167 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 1162 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 3476 | 0.070 |
Why?
|
| Habituation, Psychophysiologic | 1 | 2006 | 16 | 0.070 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2006 | 30 | 0.060 |
Why?
|
| Hyperalgesia | 1 | 2005 | 27 | 0.060 |
Why?
|
| Synapses | 3 | 2005 | 468 | 0.060 |
Why?
|
| Phenotype | 1 | 2015 | 4532 | 0.060 |
Why?
|
| Muscimol | 1 | 2005 | 9 | 0.060 |
Why?
|
| GABA-A Receptor Agonists | 1 | 2005 | 6 | 0.060 |
Why?
|
| DNA Copy Number Variations | 2 | 2021 | 1022 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2005 | 1306 | 0.060 |
Why?
|
| Gene Duplication | 2 | 2016 | 371 | 0.050 |
Why?
|
| Random Allocation | 1 | 2005 | 450 | 0.050 |
Why?
|
| Electroporation | 1 | 2003 | 34 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2005 | 905 | 0.050 |
Why?
|
| Calmodulin | 1 | 2003 | 224 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2005 | 1046 | 0.050 |
Why?
|
| Receptors, Drug | 1 | 2002 | 40 | 0.050 |
Why?
|
| Cannabinoids | 1 | 2002 | 33 | 0.050 |
Why?
|
| Synaptic Transmission | 2 | 2020 | 369 | 0.050 |
Why?
|
| Geniculate Bodies | 1 | 2001 | 11 | 0.050 |
Why?
|
| Memory, Long-Term | 1 | 2022 | 40 | 0.050 |
Why?
|
| Reaction Time | 1 | 2001 | 184 | 0.040 |
Why?
|
| Rats | 2 | 2005 | 3879 | 0.040 |
Why?
|
| Interneurons | 1 | 2022 | 153 | 0.040 |
Why?
|
| In Vitro Techniques | 3 | 2010 | 991 | 0.040 |
Why?
|
| Genes, Lethal | 1 | 2020 | 77 | 0.040 |
Why?
|
| Hindlimb | 1 | 2020 | 85 | 0.040 |
Why?
|
| Memory Disorders | 1 | 2022 | 235 | 0.040 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2013 | 130 | 0.040 |
Why?
|
| Electric Stimulation | 2 | 2014 | 326 | 0.040 |
Why?
|
| Gene Deletion | 2 | 2018 | 809 | 0.040 |
Why?
|
| Humans | 9 | 2023 | 133854 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2019 | 400 | 0.040 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2018 | 13 | 0.040 |
Why?
|
| Wakefulness | 1 | 2019 | 103 | 0.040 |
Why?
|
| Hypoglossal Nerve | 1 | 2018 | 14 | 0.040 |
Why?
|
| Gliosis | 1 | 2018 | 33 | 0.040 |
Why?
|
| Homozygote | 1 | 2020 | 560 | 0.040 |
Why?
|
| Protein Aggregates | 1 | 2018 | 37 | 0.040 |
Why?
|
| Inflammation | 1 | 2005 | 1595 | 0.040 |
Why?
|
| Protein Stability | 1 | 2018 | 172 | 0.030 |
Why?
|
| Heterozygote | 1 | 2020 | 718 | 0.030 |
Why?
|
| Neuromuscular Junction | 1 | 2018 | 101 | 0.030 |
Why?
|
| Ataxin-1 | 1 | 2018 | 162 | 0.030 |
Why?
|
| Diaphragm | 1 | 2018 | 100 | 0.030 |
Why?
|
| Periodicity | 1 | 2017 | 55 | 0.030 |
Why?
|
| Supranuclear Palsy, Progressive | 1 | 2016 | 34 | 0.030 |
Why?
|
| Age of Onset | 1 | 2018 | 635 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2016 | 317 | 0.030 |
Why?
|
| Spinal Cord | 1 | 2018 | 318 | 0.030 |
Why?
|
| Attachment Sites, Microbiological | 1 | 2015 | 7 | 0.030 |
Why?
|
| Action Potentials | 1 | 2019 | 524 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 2017 | 317 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 433 | 0.030 |
Why?
|
| Sleep | 1 | 2019 | 369 | 0.030 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2010 | 174 | 0.030 |
Why?
|
| Body Weight | 1 | 2020 | 1034 | 0.030 |
Why?
|
| Anxiety Disorders | 1 | 2001 | 725 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 397 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 813 | 0.030 |
Why?
|
| Theta Rhythm | 1 | 2014 | 24 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2014 | 68 | 0.030 |
Why?
|
| Integrases | 1 | 2015 | 163 | 0.030 |
Why?
|
| Survival Rate | 1 | 2020 | 2207 | 0.030 |
Why?
|
| Mosaicism | 1 | 2016 | 248 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2018 | 711 | 0.030 |
Why?
|
| Pedigree | 1 | 2018 | 1694 | 0.030 |
Why?
|
| Electrodes, Implanted | 1 | 2014 | 169 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 2014 | 300 | 0.030 |
Why?
|
| Actin-Related Protein 2-3 Complex | 1 | 2013 | 11 | 0.030 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2013 | 28 | 0.030 |
Why?
|
| Hyperkinesis | 1 | 2013 | 27 | 0.030 |
Why?
|
| Lithium | 1 | 2013 | 71 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2013 | 104 | 0.030 |
Why?
|
| Base Sequence | 1 | 2018 | 3171 | 0.030 |
Why?
|
| Anxiety | 1 | 2020 | 992 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2018 | 927 | 0.030 |
Why?
|
| Valproic Acid | 1 | 2013 | 168 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2016 | 1702 | 0.020 |
Why?
|
| Depressive Disorder, Major | 1 | 2018 | 468 | 0.020 |
Why?
|
| Homeostasis | 1 | 2016 | 748 | 0.020 |
Why?
|
| Drosophila | 1 | 2016 | 824 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2013 | 290 | 0.020 |
Why?
|
| Actins | 1 | 2013 | 352 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 2656 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1735 | 0.020 |
Why?
|
| Receptors, AMPA | 1 | 2010 | 51 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 3751 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 2016 | 875 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 7200 | 0.020 |
Why?
|
| Nociceptors | 1 | 2005 | 17 | 0.020 |
Why?
|
| Freund's Adjuvant | 1 | 2005 | 27 | 0.020 |
Why?
|
| Adult | 2 | 2018 | 31925 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2006 | 292 | 0.010 |
Why?
|
| Long-Term Synaptic Depression | 1 | 2003 | 13 | 0.010 |
Why?
|
| Microinjections | 1 | 2003 | 51 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 129 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 166 | 0.010 |
Why?
|
| Cannabinoid Receptor Modulators | 1 | 2002 | 7 | 0.010 |
Why?
|
| Receptors, Cannabinoid | 1 | 2002 | 10 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 472 | 0.010 |
Why?
|
| Infant | 1 | 2018 | 13135 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2003 | 401 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 14776 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2002 | 281 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2003 | 365 | 0.010 |
Why?
|
| Piperidines | 1 | 2002 | 239 | 0.010 |
Why?
|
| Motor Activity | 1 | 2003 | 537 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2002 | 328 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 1760 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 20517 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 29371 | 0.010 |
Why?
|
| Child | 1 | 2018 | 25712 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 6584 | 0.010 |
Why?
|